1. Drug delivery systems: entering the mainstream;Allen;Science,2004
2. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy;Chang;Int. J. Nanomed.,2012
3. Liposomes in drug delivery: progress and limitations;Sharma;Int. J. Pharm.,1997
4. Food and Drug Administration (FDA), Guidance for Industry, Liposome Drug Products, Guidance. 2191 (2002).
5. European Medicines Agency (EMA), Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal product, EMA/CHMP/806058/2009/Rev. 02. (2013).